AI-assisted design and virtual profiling of targeted degraders for pancreatic cancer therapy via PROTAC technology.
Pancreatic cancer remains one of the most lethal malignancies because of late diagnosis, aggressive progression, therapy resistance, and limited effective treatment options. Bromodomain-containing protein 4 (BRD4) is an important epigenetic regulator implicated in pancreatic cancer progression through its role in trans...